SphereBio
Main Vertical
BioTech
Website
CEO/FOUNDER
Name and Surname
Julieta Luz Porta
Linkedin Profile or Bio
Name and Surname
Guido Nicolás Molina
Linkedin Profile or Bio
Name and Surname
Martin Guerrero Gimenez
Linkedin Profile or Bio
Number of people on the Staff
9
Legal Form
Single-Member Corporation (SAU)
Year of Founding
2023
Type of Company
Startup
Development Stage
Traction
Province
City of Buenos Aires
City
Campos Salles 1138, C1429 Cdad. Autónoma de Buenos Aires
Main Business Model
B2B
Problem
Many advanced therapies (such as RNA, protein, CRISPR, or immunomodulators) fail because their therapeutic molecules become trapped inside endosomes and do not reach the cytoplasm, where they are intended to act. This phenomenon, called endosomal trapping, affects more than 99% of molecules administered intracellularly.
Solutions Offered - Summary
Safe, efficient, and personalized intracellular delivery.
Solutions Offered - Details
SphereBio develops XSpheres™, a nanovehicle platform enabling efficient intracellular delivery of therapeutic molecules by overcoming endosomal trapping. Our first clinical application, OncoSpheres™, uses patient-derived tumor vesicles to create personalized cancer vaccines for highly complex tumors such as glioblastoma.
Technologies Used
Artificial Intelligence
Counterparties of Interest abroad
Accelerator, Financing, Local Partner
Industries served
Biotechnology, Health, HealthTech, Pharmaceutical
International Presence
UNITED STATES
Investment Round:
Pre-Seed
Awards/Recognitions
Ganadora de Latam Health Champions 2025 (Latinoamérica) Ganadora de Meaningful Business 100 (MB100) – Liderazgo global con propó
Presentation
E-mail
info@spherebio.co